2023
DOI: 10.1016/j.onano.2022.100111
|View full text |Cite
|
Sign up to set email alerts
|

Theoretical and applied concepts of nanocarriers for the treatment of Parkinson's diseases

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

0
4
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4
2
1

Relationship

0
7

Authors

Journals

citations
Cited by 8 publications
(4 citation statements)
references
References 157 publications
0
4
0
Order By: Relevance
“…Therefore, what is observed in the documents is that nanoparticles, nanomaterials, quantum rods, liposomes, chitosan, borneol and modi ed lactoferrin are common compounds that have been investigated in their interaction with Selegiline [91,92]. Also, several valuable works of molecular dynamics simulations, and ab initio and DFT calculations on Selegiline and its energetic interaction in various chemical environments have been reported in the literature [93][94][95][96]. In this matter, accurate calculations of molecular PESs and intramolecular interaction studies are essential, and the accuracy of these calculations is the biggest challenge for pharmaceutical computational scientists.…”
Section: Introductionmentioning
confidence: 99%
“…Therefore, what is observed in the documents is that nanoparticles, nanomaterials, quantum rods, liposomes, chitosan, borneol and modi ed lactoferrin are common compounds that have been investigated in their interaction with Selegiline [91,92]. Also, several valuable works of molecular dynamics simulations, and ab initio and DFT calculations on Selegiline and its energetic interaction in various chemical environments have been reported in the literature [93][94][95][96]. In this matter, accurate calculations of molecular PESs and intramolecular interaction studies are essential, and the accuracy of these calculations is the biggest challenge for pharmaceutical computational scientists.…”
Section: Introductionmentioning
confidence: 99%
“…One such approach involves enhancing the effectiveness of therapeutics by attaching them to nanocarriers that are functionalized with appropriate ligands. This strategy enables targeted delivery to speci c sites in the body, particularly the brain, thereby improving the treatment of Parkinson's disease and minimizing any adverse effects [10].…”
Section: Introductionmentioning
confidence: 99%
“…Hence, nanotechnology is an emerging approach in the battle against PD, both in transforming the delivery of therapeutics and creating an entirely new class of therapies able to target canonical challenges of this complex disorder. 16 Graphene is investigated as a potential nanomaterial in biomedical applications, stem cell research, cell imaging, and drug/gene delivery due to its excellent conductivity, stability, and biocompatibility. 17 Graphene-based nanomaterials (GBNs) with large surface area, high electrical conductivity, and excellent mechanical performance have made their way to the forefront of nanomedicine.…”
Section: Introductionmentioning
confidence: 99%
“…Hence, nanotechnology is an emerging approach in the battle against PD, both in transforming the delivery of therapeutics and creating an entirely new class of therapies able to target canonical challenges of this complex disorder. 16…”
Section: Introductionmentioning
confidence: 99%